Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate

Author:

Alonso‐Miguel Daniel1ORCID,Valdivia Guillermo1ORCID,García‐San José Paula1ORCID,Alonso‐Diez Ángela1ORCID,Clares Irene1,Portero Miriam1,Peña Laura1ORCID,Pérez‐Alenza Maria Dolores1ORCID

Affiliation:

1. Department of Animal Medicine and Surgery, School of Veterinary Medicine Complutense University of Madrid Madrid Spain

Funder

Universidad Complutense de Madrid

Publisher

Wiley

Subject

General Veterinary

Reference47 articles.

1. Inflammatory mammary carcinoma in the dog;Susaneck SJ;J Am Anim Hosp Assoc,1983

2. Inflammatory mammary carcinoma in dogs: 33 cases (1995‐1999);Perez Alenza MD;J Am Vet Med Assoc,2001

3. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003‐2008);Marconato L;J Am Vet Med Assoc,2009

4. Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase‐2 expression, and response to piroxicam treatment;M Souza CH;Can Vet J,2009

5. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases;Pena L;Breast Cancer Res Treat,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3